D. E. Shaw & Co., Inc. - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 35 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$31,000
-73.9%
15,400
-74.2%
0.00%
Q2 2014$119,000
-26.1%
59,713
+14.5%
0.00%
Q1 2014$161,000
-6.9%
52,163
+1.2%
0.00%
Q4 2013$173,000
+47.9%
51,562
+40.7%
0.00%
Q3 2013$117,000
+33.0%
36,648
+25.1%
0.00%
Q2 2013$88,00029,2850.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,031,874$6,258,0006.29%
NEA Management Company, LLC 2,086,755$6,427,0000.32%
BVF INC/IL 150,000$462,0000.07%
Central Square Management LLC 19,000$59,0000.06%
ABNER HERRMAN & BROCK LLC 20,000$62,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$422,0000.01%
SHEPHERD KAPLAN KROCHUK, LLC 31,000$95,0000.01%
Spark Investment Management LLC 11,100$34,0000.01%
Waverly Advisors, LLC 2,670$8,0000.00%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 33,384$103,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders